CN116947658A - A kind of synthesis method of 1-amino-2-methyl-2-propanol - Google Patents
A kind of synthesis method of 1-amino-2-methyl-2-propanol Download PDFInfo
- Publication number
- CN116947658A CN116947658A CN202310940677.2A CN202310940677A CN116947658A CN 116947658 A CN116947658 A CN 116947658A CN 202310940677 A CN202310940677 A CN 202310940677A CN 116947658 A CN116947658 A CN 116947658A
- Authority
- CN
- China
- Prior art keywords
- methyl
- amino
- compound
- add
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LXQMHOKEXZETKB-UHFFFAOYSA-N 1-amino-2-methylpropan-2-ol Chemical compound CC(C)(O)CN LXQMHOKEXZETKB-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 238000001308 synthesis method Methods 0.000 title claims abstract description 6
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims abstract description 20
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 claims abstract description 18
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003960 organic solvent Substances 0.000 claims abstract description 13
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims abstract description 10
- TXTWXQXDMWILOF-UHFFFAOYSA-N (2-ethoxy-2-oxoethyl)azanium;chloride Chemical compound [Cl-].CCOC(=O)C[NH3+] TXTWXQXDMWILOF-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000007818 Grignard reagent Substances 0.000 claims abstract description 9
- 150000004795 grignard reagents Chemical class 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 6
- 239000005051 trimethylchlorosilane Substances 0.000 claims abstract description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 81
- 238000006243 chemical reaction Methods 0.000 claims description 62
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 38
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical group CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 21
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 19
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 14
- 238000003756 stirring Methods 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 238000010189 synthetic method Methods 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- 125000001033 ether group Chemical group 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 150000002148 esters Chemical class 0.000 abstract description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 46
- 239000012071 phase Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000005457 ice water Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 3
- 238000006969 Curtius rearrangement reaction Methods 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- CNIBHMMDDXGDNR-UHFFFAOYSA-N ethyl 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate Chemical compound CCOC(=O)CNC(=O)OC(C)(C)C CNIBHMMDDXGDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- RWBRUCCWZPSBFC-UHFFFAOYSA-N 17-(1-hydroxyethyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(O)C)C1(C)CC2 RWBRUCCWZPSBFC-UHFFFAOYSA-N 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- AXFYFNCPONWUHW-UHFFFAOYSA-N beta-hydroxy-beta-methyl butyric acid Natural products CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000006462 rearrangement reaction Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域Technical field
本发明涉及有机合成技术领域,具体涉及一种1-氨基-2-甲基-2-丙醇的合成方法。The invention relates to the technical field of organic synthesis, and specifically relates to a synthesis method of 1-amino-2-methyl-2-propanol.
背景技术Background technique
有报道以β-羟基异戊酸为原料,通过Curtius反应,重排生成氨基化合物(CN106496085)。但是这个方法使用叠氮磷酸二苯酯(DPPA),在重排反应中,会有大量氮气产生,比较危险,不适合大规模合成。It has been reported that β-hydroxyisovaleric acid is used as raw material and rearranged to generate amino compounds through Curtius reaction (CN106496085). However, this method uses diphenylphosphoryl azide (DPPA). During the rearrangement reaction, a large amount of nitrogen will be generated, which is relatively dangerous and is not suitable for large-scale synthesis.
发明内容Contents of the invention
一种1-氨基-2-甲基-2-丙醇的合成方法,包括:A synthetic method of 1-amino-2-methyl-2-propanol, including:
进一步地,所述的碱为三乙胺、氢氧化钠、氢氧化钾或碳酸氢钠中的一种或几种。Further, the base is one or more of triethylamine, sodium hydroxide, potassium hydroxide or sodium bicarbonate.
进一步地,化合物II制备化合物III的步骤中,甘氨酸乙酯盐酸盐、二碳酸二叔丁酯、碱的摩尔比为1:1~1.1:1~2.0。Further, in the step of preparing compound III from compound II, the molar ratio of glycine ethyl ester hydrochloride, di-tert-butyl dicarbonate, and base is 1:1 to 1.1: 1 to 2.0.
进一步地,化合物II制备化合物III的步骤中,在冰浴下,在有机溶剂1中,加入甘氨酸乙酯盐酸盐和三乙胺,然后滴加二碳酸二叔丁酯,控制滴加速度,使反应液温度不超过20℃,搅拌反应;Further, in the step of preparing compound III from compound II, add glycine ethyl ester hydrochloride and triethylamine to organic solvent 1 under an ice bath, and then add di-tert-butyl dicarbonate dropwise, and control the dropping speed to make The temperature of the reaction solution does not exceed 20°C, and the reaction is stirred;
其中,所述的有机溶剂1为二氯甲烷、四氢呋喃、甲醇、正己烷、正庚烷、甲叔醚、甲苯中的一种或几种。Wherein, the organic solvent 1 is one or more of dichloromethane, tetrahydrofuran, methanol, n-hexane, n-heptane, methyl tertiary ether, and toluene.
进一步地,在化合物III制备化合物Ⅳ的步骤中,在冰浴下,在有机溶剂2中加入化合物III,反应体系置换成氮气,滴加格氏试剂至反应液中,使反应温度不超过室温,搅拌反应;Further, in the step of preparing compound IV from compound III, add compound III to organic solvent 2 under an ice bath, replace the reaction system with nitrogen, add Grignard reagent dropwise to the reaction solution, so that the reaction temperature does not exceed room temperature, Stir the reaction;
其中,所述的有机溶剂2为二氯甲烷、四氢呋喃、甲醇、正己烷、正庚烷、甲叔醚、甲苯中的一种或几种。Wherein, the organic solvent 2 is one or more of dichloromethane, tetrahydrofuran, methanol, n-hexane, n-heptane, methyl tertiary ether, and toluene.
进一步地,所述的格氏试剂为甲基溴化镁、甲基碘化镁或者CH3X和金属镁反应生成CH3XMg,其中X为Cl、Br或I。Further, the Grignard reagent is methylmagnesium bromide, methylmagnesium iodide or CH 3 X reacts with metal magnesium to generate CH 3 XMg, where X is Cl, Br or I.
进一步地,化合物III、格氏试剂摩尔比为:1:2.2。Further, the molar ratio of compound III to Grignard reagent is: 1:2.2.
进一步地,化合物Ⅳ制备化合物Ⅰ的步骤中,在冰浴下,在有机溶剂3中加入化合物Ⅳ,滴加三甲基氯硅烷,使反应温度不超过室温,搅拌反应;Further, in the step of preparing compound I from compound IV, compound IV is added to organic solvent 3 under an ice bath, trimethylsilyl chloride is added dropwise, so that the reaction temperature does not exceed room temperature, and the reaction is stirred;
其中,所述的有机溶剂3为二氯甲烷、四氢呋喃、甲醇、正己烷、正庚烷、甲叔醚、甲苯中的一种或几种。Wherein, the organic solvent 3 is one or more of dichloromethane, tetrahydrofuran, methanol, n-hexane, n-heptane, methyl tertiary ether, and toluene.
进一步地,化合物Ⅳ与三甲基氯硅烷的摩尔比为1:1.1~2。Further, the molar ratio of compound IV to trimethylchlorosilane is 1:1.1-2.
进一步地,整个反应过程的溶剂为二氯甲烷、四氢呋喃、甲醇、正己烷、正庚烷、甲叔醚、甲苯中的一种或几种。Further, the solvent of the entire reaction process is one or more of dichloromethane, tetrahydrofuran, methanol, n-hexane, n-heptane, methyl tertiary ether, and toluene.
本申请的有益效果为:本方法采用廉价的甘氨酸乙酯盐酸盐为原料,先用Boc保护氨基,再采用格氏试剂和酯反应,生成三级羟基。本方法操作简单,收率较高,适合大规模生产。The beneficial effects of this application are as follows: This method uses cheap glycine ethyl ester hydrochloride as raw material, first uses Boc to protect the amino group, and then uses Grignard reagent and ester reaction to generate tertiary hydroxyl groups. This method is simple to operate, has a high yield, and is suitable for large-scale production.
附图说明Description of the drawings
图1为本发明的一种1-氨基-2-甲基-2-丙醇的合成方法实施例1中制备得到的产品的气相图谱。Figure 1 is a gas phase spectrum of the product prepared in Example 1 of a synthesis method of 1-amino-2-methyl-2-propanol of the present invention.
图2为本发明的一种1-氨基-2-甲基-2-丙醇的合成方法实施例1中制备得到的产品的氢谱图。Figure 2 is a hydrogen spectrum of the product prepared in Example 1 of the synthesis method of 1-amino-2-methyl-2-propanol of the present invention.
具体实施方式Detailed ways
为了便于对申请的技术方案进行理解,现通过实施例对技术方案进行进一步解释说明。In order to facilitate understanding of the technical solution of the application, the technical solution is now further explained through examples.
实施例1Example 1
化合物II制备化合物III的具体步骤如下:The specific steps for preparing compound III from compound II are as follows:
把3.5L二氯甲烷加入到5L四口瓶中,加入甘氨酸乙酯盐酸盐837g(6mol,1eq),再加入三乙胺667g(6.6mol,1.1eq),把反应液用冰水浴冷却,使反应液内温在10℃左右。把二碳酸二叔丁酯1439g(6.6mol,1.1eq)转移至恒压滴液漏斗中,慢慢滴加至反应液,控制滴加速度,使反应液温度不超过20℃,约1h滴加完。后继续搅拌反应4h。反应液用2L饱和碳酸氢钠溶液洗2次,再用1L饱和食盐水洗一次。二氯甲烷相用无水硫酸钠干燥,再过滤,滤液减压旋蒸,得到N-Boc甘氨酸乙酯(化合物III)1195g,产率为98%。气相显示纯度为99.5%。直接用作下一步。Add 3.5L methylene chloride to a 5L four-neck flask, add 837g glycine ethyl ester hydrochloride (6mol, 1eq), then add 667g triethylamine (6.6mol, 1.1eq), and cool the reaction solution in an ice water bath. Keep the internal temperature of the reaction solution at about 10°C. Transfer 1439g of di-tert-butyl dicarbonate (6.6mol, 1.1eq) into a constant pressure dropping funnel, slowly add it dropwise to the reaction solution, control the dropping speed so that the temperature of the reaction solution does not exceed 20°C, and complete the dropwise addition in about 1 hour. . Then continue to stir the reaction for 4 hours. The reaction solution was washed twice with 2 L of saturated sodium bicarbonate solution and once with 1 L of saturated brine. The dichloromethane phase was dried over anhydrous sodium sulfate, then filtered, and the filtrate was evaporated under reduced pressure to obtain 1195 g of N-Boc glycine ethyl ester (compound III) with a yield of 98%. The gas phase showed a purity of 99.5%. Use it directly for the next step.
在化合物III制备化合物Ⅳ的步骤如下:The steps for preparing compound IV from compound III are as follows:
将1.5L无水四氢呋喃加入到5L四口瓶中,后加入上步得到的化合物III 609g(3mol,1eq),后把反应液放置于冰水浴中,使反应液内温为5℃左右。反应体系置换成氮气。慢慢滴加3M甲基溴化镁2.2L(6.6mol,2.2eq)至反应液中,使反应液温度不超过10℃,约3h滴加完。滴加结束后,让反应液逐渐升至室温,继续搅拌反应10h。TLC显示反应结束。配置4NHCl1L,并滴加至反应液。后把反应液减压旋蒸,蒸馏出大部分四氢呋喃,加入1L二氯甲烷,搅拌10min。静置分层后,水相用1L二氯甲烷萃取。合并二氯甲烷相,分别用1L饱和碳酸氢钠溶液,1L水洗。后把二氯甲烷相减压蒸馏,先低温蒸出二氯甲烷,后用油泵把产品化合物Ⅳ蒸出,得到467.7g,产率为82.5%。Add 1.5L anhydrous tetrahydrofuran to a 5L four-neck flask, then add 609g (3mol, 1eq) of compound III obtained in the previous step, and then place the reaction solution in an ice-water bath to keep the internal temperature of the reaction solution at about 5°C. The reaction system was replaced with nitrogen. Slowly add 2.2L of 3M methylmagnesium bromide (6.6 mol, 2.2eq) dropwise into the reaction solution so that the temperature of the reaction solution does not exceed 10°C. The addition will be completed in about 3 hours. After the dropwise addition was completed, the reaction solution was allowed to gradually rise to room temperature, and the reaction was continued to stir for 10 h. TLC showed the reaction was complete. Prepare 1L of 4NHCl and add dropwise to the reaction solution. Then, the reaction solution was rotary evaporated under reduced pressure to distill out most of the tetrahydrofuran. Add 1 L of methylene chloride and stir for 10 minutes. After standing for separation, the aqueous phase was extracted with 1L methylene chloride. Combine the dichloromethane phases and wash with 1L saturated sodium bicarbonate solution and 1L water respectively. Afterwards, the methylene chloride phase was distilled under reduced pressure. The methylene chloride was first evaporated at low temperature, and then the product compound IV was evaporated using an oil pump to obtain 467.7g, with a yield of 82.5%.
第2步反应条件优化结果Optimization results of reaction conditions in step 2
化合物Ⅳ制备化合物Ⅰ的步骤如下:The steps for preparing compound I from compound IV are as follows:
把5L二氯甲烷加入到10L四口瓶中,后加入1L甲醇,再加入化合物Ⅳ756g(4mol,1eq),把反应液放置于冰水浴,反应液温度为0-5℃,滴加三甲基氯硅烷653g(6mol,1.5eq),滴加时使反应液温度不超过5℃,约2h滴完。后把反应液置于油浴加热,内温为35℃反应4h。往反应液中加入饱和碳酸氢钠溶液2L,并搅拌30min。静置分层后,二氯甲烷相再用1L水洗两次。后用水泵减压蒸馏,由于产品A4的沸点较低,加30cm精馏柱(玻璃填料)可使产品和二氯甲烷完全分开。得到产品化合物Ⅰ342.5g,产率96%。GC显示纯度为99.75%,如图1所示。HNMR(400MHz,Chloroform-d)δ:2.54(s,2H),2.03(s,2H),1.12(s,6H)ppm,如图2所示。Add 5L methylene chloride into a 10L four-neck bottle, then add 1L methanol, then add 756g of compound IV (4mol, 1eq), place the reaction solution in an ice water bath, the temperature of the reaction solution is 0-5°C, and add trimethyltrimethyl dropwise 653g of chlorosilane (6mol, 1.5eq) should be added dropwise so that the temperature of the reaction solution does not exceed 5°C, and the drops should be completed in about 2 hours. Finally, the reaction solution was placed in an oil bath and heated to an internal temperature of 35°C for 4 hours. Add 2L of saturated sodium bicarbonate solution to the reaction solution and stir for 30 minutes. After standing for separation, the dichloromethane phase was washed twice with 1 L of water. Then use a water pump to distill under reduced pressure. Since the boiling point of product A4 is low, adding a 30cm distillation column (glass packing) can completely separate the product and methylene chloride. 342.5 g of product compound I was obtained with a yield of 96%. GC showed a purity of 99.75% as shown in Figure 1. HNMR (400MHz, Chloroform-d) δ: 2.54 (s, 2H), 2.03 (s, 2H), 1.12 (s, 6H) ppm, as shown in Figure 2.
实施例2Example 2
化合物II制备化合物III的具体步骤如下:The specific steps for preparing compound III from compound II are as follows:
把3.5L二氯甲烷加入到5L四口瓶中,后一次性加入甘氨酸乙酯盐酸盐837g(6mol,1eq),再加入N,N-二异丙基乙胺852.7g(6.6mol,1.1eq),把反应液用冰水浴冷却,使反应液内温在10℃左右。把二碳酸二叔丁酯1439g(6.6mol,1.1eq)转移至恒压滴液漏斗中,慢慢滴加至反应液,控制滴加速度,使反应液温度不超过20℃.约1h滴加完。后继续搅拌反应4h。反应液用2L饱和碳酸氢钠溶液洗2次,再用1L饱和食盐水洗一次。二氯甲烷相用无水硫酸钠干燥,再过滤,滤液减压旋蒸,得到产品N-Boc甘氨酸乙酯(化合物III)1108g,产率为91%。气相显示纯度为99%。Add 3.5L methylene chloride into a 5L four-neck bottle, then add 837g glycine ethyl ester hydrochloride (6mol, 1eq) in one go, and then add 852.7g N,N-diisopropylethylamine (6.6mol, 1.1 eq), cool the reaction solution in an ice-water bath to keep the internal temperature of the reaction solution at about 10°C. Transfer 1439g of di-tert-butyl dicarbonate (6.6mol, 1.1eq) into a constant pressure dropping funnel and slowly add it dropwise to the reaction solution. Control the dropping speed so that the temperature of the reaction solution does not exceed 20°C. The addition will be completed in about 1 hour. . Then continue to stir the reaction for 4 hours. The reaction solution was washed twice with 2 L of saturated sodium bicarbonate solution and once with 1 L of saturated brine. The dichloromethane phase was dried over anhydrous sodium sulfate, then filtered, and the filtrate was evaporated under reduced pressure to obtain 1108 g of product N-Boc glycine ethyl ester (compound III) with a yield of 91%. The gas phase showed a purity of 99%.
在化合物III制备化合物Ⅳ的步骤如下:The steps for preparing compound IV from compound III are as follows:
将1.5L无水四氢呋喃加入到5L四口瓶中,后加入上步得到的化合物III 609g(3mol,1eq),后把反应液放置于冰水浴中,使反应液内温为5℃左右。反应体系置换成氮气。慢慢滴加3M甲基溴化镁2.2L(6.6mol,2.2eq)至反应液中,使反应液温度不超过10℃,约3h滴加完。滴加结束后,让反应液逐渐升至室温,继续搅拌反应10h。TLC显示反应结束。把反应液转移到10L四口瓶中,配制4NHCl1L,并滴加至反应液。后把反应液减压旋蒸,蒸馏出大部分四氢呋喃,加入1L二氯甲烷,搅拌10min。静置分层后,水相用1L二氯甲烷萃取。合并二氯甲烷相,分别用1L饱和碳酸氢钠溶液,1L水洗。后把二氯甲烷相减压蒸馏,先低温蒸出二氯甲烷,后用油泵把产品化合物Ⅳ蒸出,得到476.8g,产率为84.1%。Add 1.5L anhydrous tetrahydrofuran to a 5L four-neck flask, then add 609g (3mol, 1eq) of compound III obtained in the previous step, and then place the reaction solution in an ice-water bath to keep the internal temperature of the reaction solution at about 5°C. The reaction system was replaced with nitrogen. Slowly add 2.2L of 3M methylmagnesium bromide (6.6 mol, 2.2eq) dropwise into the reaction solution so that the temperature of the reaction solution does not exceed 10°C. The addition will be completed in about 3 hours. After the dropwise addition was completed, the reaction solution was allowed to gradually rise to room temperature, and the reaction was continued to stir for 10 h. TLC showed the reaction was complete. Transfer the reaction solution to a 10L four-neck bottle, prepare 1L of 4NHCl, and add it dropwise to the reaction solution. Then, the reaction solution was rotary evaporated under reduced pressure to distill out most of the tetrahydrofuran. Add 1 L of methylene chloride and stir for 10 minutes. After standing for separation, the aqueous phase was extracted with 1L methylene chloride. Combine the dichloromethane phases and wash with 1L saturated sodium bicarbonate solution and 1L water respectively. The methylene chloride phase was then distilled under reduced pressure. The methylene chloride was first evaporated at low temperature, and then the product compound IV was evaporated using an oil pump to obtain 476.8 g, with a yield of 84.1%.
化合物Ⅳ制备化合物Ⅰ的步骤如下:The steps for preparing compound I from compound IV are as follows:
把5L甲醇加入到10L四口瓶中,后加入化合物Ⅳ756g(4mol,1eq),把反应液放置于冰水浴,反应液温度为0-5℃,滴加三甲基氯硅烷518.5g(4.8mol,1.2eq),滴加时使反应液温度不超过5℃,约2h滴完。后把反应液置于油浴加热,内温为35℃反应4h。后把反应液旋干,再往反应体系中加入二氯甲烷5L,再加入饱和碳酸氢钠溶液2L,并搅拌30min。静置分层后,二氯甲烷相再用1L水洗两次。后用水泵减压蒸馏,由于产品化合物Ⅰ的沸点较低,加30cm精馏柱(玻璃填料)可使产品和二氯甲烷完全分开。得到产品化合物Ⅰ217.2g,产率61%。GC显示纯度为99%。Add 5L methanol into a 10L four-neck flask, and then add 756g (4mol, 1eq) of compound IV. Place the reaction solution in an ice water bath. The temperature of the reaction solution is 0-5°C. Add 518.5g (4.8mol) of trimethylchlorosilane dropwise. ,1.2eq), when adding dropwise, the temperature of the reaction solution should not exceed 5°C, and the dripping should be completed in about 2 hours. Finally, the reaction solution was placed in an oil bath and heated to an internal temperature of 35°C for 4 hours. Then spin the reaction liquid to dryness, add 5L of methylene chloride to the reaction system, then add 2L of saturated sodium bicarbonate solution, and stir for 30 minutes. After standing for separation, the dichloromethane phase was washed twice with 1 L of water. Then use a water pump to distill under reduced pressure. Since the boiling point of the product compound I is low, adding a 30cm distillation column (glass packing) can completely separate the product and methylene chloride. 217.2 g of product compound I was obtained with a yield of 61%. GC showed 99% purity.
以上所述,仅是本申请的几个实施例,并非对本申请做任何形式的限制,虽然本申请以较佳实施例揭示如上,然而并非用以限制本申请,任何熟悉本专业的技术人员,在不脱离本申请技术方案的范围内,利用上述揭示的技术内容做出些许的变动或修饰均等同于等效实施案例,均属于技术方案范围内。The above are only a few embodiments of the present application, and are not intended to limit the present application in any way. Although the present application is disclosed as above with preferred embodiments, they are not intended to limit the present application. Any skilled person familiar with this field, Without departing from the scope of the technical solution of this application, slight changes or modifications made using the technical content disclosed above are equivalent to equivalent implementation examples and fall within the scope of the technical solution.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310940677.2A CN116947658A (en) | 2023-07-28 | 2023-07-28 | A kind of synthesis method of 1-amino-2-methyl-2-propanol |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310940677.2A CN116947658A (en) | 2023-07-28 | 2023-07-28 | A kind of synthesis method of 1-amino-2-methyl-2-propanol |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116947658A true CN116947658A (en) | 2023-10-27 |
Family
ID=88444321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310940677.2A Pending CN116947658A (en) | 2023-07-28 | 2023-07-28 | A kind of synthesis method of 1-amino-2-methyl-2-propanol |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116947658A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977178A (en) * | 1995-12-22 | 1999-11-02 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
CN114269346A (en) * | 2019-07-08 | 2022-04-01 | 普渡研究基金会 | Compounds and methods for treating and preventing fibrotic disease states and cancer |
CN115038688A (en) * | 2019-09-11 | 2022-09-09 | 文森雷生物科学股份有限公司 | USP30 inhibitors and their uses |
WO2022187329A1 (en) * | 2021-03-03 | 2022-09-09 | The Board Of Trustees Of The University Of Illinois | Fabi inhibitors for gram-negative pathogens |
WO2023058645A1 (en) * | 2021-10-05 | 2023-04-13 | Eaファーマ株式会社 | Method for producing compound or pharmaceutically acceptable salt thereof |
-
2023
- 2023-07-28 CN CN202310940677.2A patent/CN116947658A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977178A (en) * | 1995-12-22 | 1999-11-02 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
CN114269346A (en) * | 2019-07-08 | 2022-04-01 | 普渡研究基金会 | Compounds and methods for treating and preventing fibrotic disease states and cancer |
CN115038688A (en) * | 2019-09-11 | 2022-09-09 | 文森雷生物科学股份有限公司 | USP30 inhibitors and their uses |
WO2022187329A1 (en) * | 2021-03-03 | 2022-09-09 | The Board Of Trustees Of The University Of Illinois | Fabi inhibitors for gram-negative pathogens |
WO2023058645A1 (en) * | 2021-10-05 | 2023-04-13 | Eaファーマ株式会社 | Method for producing compound or pharmaceutically acceptable salt thereof |
Non-Patent Citations (1)
Title |
---|
SIMON JONES等: "N-Phosphoryl oxazolidinones as effective phosphorylating agents", 《TETRAHEDRON LETTERS》, vol. 45, 31 December 2004 (2004-12-31), pages 1585 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023284058A1 (en) | Method for preparing chiral synthetic nicotine | |
CN116947658A (en) | A kind of synthesis method of 1-amino-2-methyl-2-propanol | |
CN106631823B (en) | Preparation method of lorcaserin intermediate | |
CN107216335B (en) | A kind of tert-butyl 1- (methylol) -3- oxa- -9- azaspiro [5.5] hendecane -9- formic acid base ester preparation method | |
TWI540119B (en) | Compound, method for producing the same, and method for producing oseltamivir phosphate | |
WO2023284057A1 (en) | Method for preparing s-nicotine | |
CN107513048B (en) | Synthesis method of deuterated vortioxetine hydrobromide | |
CN107540575B (en) | Preparation method of sitagliptin intermediate | |
CN115286504B (en) | Method for synthesizing (R) -2- (2- (tert-butoxy) -2-oxyethyl) pentanoic acid | |
WO2017177715A1 (en) | Method for preparing chiral ferrocene p, p ligand | |
CN102675415A (en) | Method for preparing bortezomib | |
CN106748826B (en) | N, N, N '-trimethyl-N '-ethoxy-ethylenediamine the preparation method | |
US6689913B2 (en) | Process for preparing terbinafine and HCI salt thereof | |
CN107216332A (en) | The synthetic method of (6H) the formic acid base ester of 7 methylol of the tert-butyl group, 7,8 dihydro 4H pyrazolos diazepine 5 | |
CN109456275A (en) | A kind of preparation method of 1H-1,2,3- triazole | |
CN102010355B (en) | Method for synthesizing (1R, 2R)-1-p-methyl sulfone phenyl-2-amino-1,3-propanediol | |
CN115894320A (en) | Synthesis method of vitamin D medicine cis-isomer impurity | |
CN110028470B (en) | Process method for producing dehydroacetic acid, patchoulenone and analogues thereof by using carbon dioxide | |
CN109574860A (en) | A kind of method for preparing vilanterol | |
CN104829468B (en) | (R)The asymmetric preparation method of albuterol hydrochloride | |
JP4667593B2 (en) | Process for producing 2-alkyl-2-adamantyl (meth) acrylates | |
CN107602337B (en) | Preparation method of 1,4-dicyano-2-butene | |
CN108203435B (en) | Preparation method of entecavir by using Boc protecting group | |
CN107501267B (en) | A kind of method for synthesizing chiral acyclic nucleoside analogs by asymmetric allyl amination reaction | |
CN112745244B (en) | Intermediate of simotimod and synthesis method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |